HPV Vaccination Attitudes and Behaviors among General Practitioners in Italy

This cross-sectional electronic online or telephone survey assessed the attitudes and behaviors regarding human papillomavirus (HPV) vaccination and the effect of different factors among a nationally representative random sample of 349 general practitioners (GPs) in Italy. A semi-structured interview was performed between September 2018 and October 2020. Almost all respondents considered the HPV vaccine safe with an overall mean value of 8.8, on a scale ranging from 1 to 10, and 59.9% and 32.6% believed that the vaccination was very effective in preventing the related diseases among 12-26 years' girls and boys. Multivariate logistic regression analysis showed that GPs who had received information about HPV vaccination from scientific journals were more likely to have positive attitude towards the effectiveness of the vaccine in preventing HPV-related diseases in girls between 12-26 years. A large majority (81.5%) of GPs who provided assistance to girls' patients aged 11-12 years often or always recommend the HPV vaccine to them, and this behavior was more likely to occur in those who believed that the vaccine was very effective in preventing HPV-related diseases in girls between 12-26 years. GPs were more likely to often or always recommend the HPV vaccine to boys aged 11-12 years if they often or always recommended the vaccine to girls aged 11-12 years, if they believed that the vaccine was very effective in preventing HPV-related diseases in boys between 12-26 years, and if they considered the HPV vaccine very safe. GPs should receive information about the HPV immunization to ensure that they routinely communicate with their patient population in order to achieve better coverage rates.

Automated summary

The survey showed that the majority of general practitioners in Italy consider the HPV vaccine to be safe and effective, with those receiving information from scientific journals more likely to have a positive attitude towards its effectiveness. The willingness and behavior of recommending the HPV vaccine may be influenced by the physician's perception of its efficacy and safety.